Evidence map›Paper›PMID 33982443›Full record

ArticleMolecular genetics & genomic medicine2021

Identification of microduplications at Xp21.2 and Xq13.1 in neurodevelopmental disorders.

Hannaleena Kokkonen, Auli Siren, Tuomo Määttä, Magda Kamila Kadlubowska, Anushree Acharya, Liz M Nouel-Saied, Suzanne M Leal, Irma Järvelä, Isabelle Schrauwen

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Hannaleena KokkonenNorthern Finland Laboratory Centre NordLab and Medical Research Centre, Oulu University Hospital and University of Oulu, Oulu, Finland.ORCID 0000-0003-2714-8876
Auli SirenKanta-Häme Central Hospital, Hämeenlinna, Finland.
Tuomo MäättäDisability Services, Joint Authority for Kainuu, Kajaani, Finland.
Magda Kamila KadlubowskaCenter for Statistical Genetics, Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Anushree AcharyaCenter for Statistical Genetics, Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0002-1889-8723
Liz M Nouel-SaiedCenter for Statistical Genetics, Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, NY, USA.
Suzanne M LealCenter for Statistical Genetics, Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0003-1231-8174
Irma JärveläDepartment of Medical Genetics, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-1770-6187
Isabelle SchrauwenCenter for Statistical Genetics, Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, NY, USA.ORCID 0000-0001-7310-6082
Columbia University Irving Medical Center · USKajaani University of Applied Sciences · FIKanta-Hämeen Keskussairaala · FIOulu University Hospital · FIUniversity of Helsinki · FI

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundMicroduplications are a rare cause of disease in X-linked neurodevelopmental disorders but likely have been under reported due challenges in detection and interpretation.

methodsWe performed exome sequencing and subsequent microarray analysis in two families with a neurodevelopmental disorder.

resultsHere, we report on two families each with unique inherited microduplications at Xp21.2 and Xq13.1, respectively. In the first family, a 562.8-kb duplication at Xq13.1 covering DLG3, TEX11, SLC7A3, GDPD2, and part KIF4A was identified in a boy whose phenotype was characterized by delayed speech development, mild intellectual disability (ID), mild dysmorphic facial features, a heart defect, and neuropsychiatric symptoms. By interrogating all reported Xq13.1 duplications in individuals affected with a neurodevelopmental disorder, we provide evidence that this genomic region and particularly DLG3 might be sensitive to an increased dosage. In the second family with four affected males, we found a noncontinuous 223- and 204-kb duplication at Xp21.2, of which the first duplication covers exon 6 of IL1RAPL1. The phenotype of the male patients was characterized by delayed speech development, mild to moderate ID, strabismus, and neurobehavioral symptoms. The carrier daughter and her mother had learning difficulties. IL1RAPL1 shows nonrecurrent causal structural variation and is located at a common fragile site (FRAXC), prone to re-arrangement.

conclusionIn conclusion, we show that comprehensive clinical and genetic examination of microduplications on the X-chromosome can be helpful in undiagnosed cases of neurodevelopmental disease.

Indexed as

Chromosome DuplicationChromosomes, Human, XGenetic Association StudiesGenetic Predisposition to DiseaseAdolescentAdultAllelesComparative Genomic HybridizationDNA Copy Number VariationsExome SequencingExonsFemaleHumansIntellectual DisabilityMaleNeurodevelopmental Disordersexome sequencingintellectual disabilitymicroduplicationneurodevelopmental disordersX-chromosome

Identifiers

PMID33982443
PMCPMC8683627
OpenAlexW3162620221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.